Wool specializes in FDA-approved, evidence-based GLP-1 peptide therapy using the most researched and clinically effective peptides for weight management Semaglutide Mechanism: GLP-1 receptor agonist Average Weight Loss: 10-15% body weight Key Benefits: Proven track record, cardiovascular benefits, reduces food and alcohol cravings, slows digestion for prolonged satiety Availability: FDA-approved, Available now Tirzepatide Mechanism: Dual GLP-1/GIP agonist Average Weight Loss: 15-22.5% body weight Key Benefits: Superior weight loss results, improved metabolic markers, potentially fewer GI side effects, enhanced insulin sensitivity Availability: FDA-approved, Available now Retatrutide (Investigational) Mechanism: GLP-1/GIP/Glucagon agonist Average Weight Loss: Up to 24% body weight Key Benefits: Best weight loss results in clinical trials, superior muscle preservation, next-generation therapy Availability: Phase 3 trials, Future availability Natural Therapies for Enhanced Results GLP-1 peptide therapy works synergistically with naturopathic approaches to optimize weight loss, minimize side effects and support long-term metabolic health
Cons: Potential side effects include gastrointestinal discomfort, reduced vitamin B12 absorption, and the risk of hypoglycemia in certain individuals
A meta-analysis by Zheng H
The Regulatory Reckoning As supply chains matured, the regulatory landscape shifted dramatically
This allows the B12 to be absorbed into the bloodstream and transported to the needed cells
